Related Experiment Video

Updated: Aug 14, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K

Update on injectable antiretrovirals at HIV Glasgow

Laura Waters1, Marta Boffito2

  • 1Department of Sexual Health & HIV, Central & North West London NHS Trust, London WC1E 6JB, UK.

The Lancet. HIV
|January 9, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.5K

Related Experiment Videos

Last Updated: Aug 14, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.5K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.4K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.4K
Subviral Agents01:29

Subviral Agents

71
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
71

Articles linked to this work by shared authors, journal, and citation graph.

Joint British association for sexual health and HIV/British HIV association guidelines for the sexual and reproductive health of people with HIV 2026.

International journal of STD & AIDS·2026

The relationship between plasma favipiravir concentrations and clinical outcomes in COVID-19.

ERJ open research·2026

Prior PrEP use and discontinuation in individuals newly diagnosed with HIV.

HIV medicine·2026

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

The lancet. HIV·2026

Evaluation of the psychometric properties of the Episodic Disability Questionnaire (EDQ) among women living with HIV in the United Kingdom: A self-reported repeated measure study.

PloS one·2026

Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV.

AIDS (London, England)·2026

Programmatic effectiveness of tuberculosis preventive treatment for people with HIV in six high-tuberculosis-burden countries (PROTECT): a prospective cohort study and meta-analysis.

The lancet. HIV·2026

Safety and immunogenicity of one or two doses of the rVSVΔG-ZEBOV-GP Ebola virus vaccine in adults and adolescents living with HIV: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.

The lancet. HIV·2026

Evolving understanding of Kaposi sarcoma and associated diseases in the ART era.

The lancet. HIV·2026

Interventions to improve viral suppression and adherence to antiretroviral therapy among people living with HIV: a systematic review and network meta-analysis.

The lancet. HIV·2026

Does U=U apply during breastfeeding? An urgent research priority.

The lancet. HIV·2026

Durability of HIV viral suppression in South Africa: a national cohort study.

The lancet. HIV·2026

Prospective evaluation of imipenem trough concentrations and clinical outcomes in critically ill patients.

The Journal of antimicrobial chemotherapy·2026

Monotypic IgA nephropathy: A large health system experience.

Clinical nephrology·2026

Association of elevated homocysteine levels with renal pathology and function in patients with IgA nephropathy: a single-center retrospective study.

Annals of medicine·2026

Intestinal Ultrasound in Inflammatory Bowel Disease: Monitoring Inflammation and Treatment Response.

Journal of inflammation research·2026

Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

Open forum infectious diseases·2026

Breaking tolerance in the glomerulus: complement as a driver and therapeutic target in IgA nephropathy.

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us